132 related articles for article (PubMed ID: 30068764)
1. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
Tselios K; Gladman DD; Harvey P; Akhtari S; Su J; Urowitz MB
J Rheumatol; 2019 Jan; 46(1):64-69. PubMed ID: 30068764
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
Tselios K; Deeb M; Gladman DD; Harvey P; Akhtari S; Mak S; Butany J; Urowitz MB
J Rheumatol; 2019 Apr; 46(4):391-396. PubMed ID: 30323009
[TBL] [Abstract][Full Text] [Related]
3. Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.
Tselios K; Gladman DD; Su J; Urowitz MB
Lupus; 2016 Apr; 25(5):532-5. PubMed ID: 26585070
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Magnetic Resonance Imaging T1 and T2 Mapping in Systemic Lupus Erythematosus in Relation to Antimalarial Treatment.
Shalmon T; Thavendiranathan P; Seidman MA; Wald RM; Karur GR; Harvey PJ; Akhtari S; Osuntokun T; Tselios K; Gladman DD; Hanneman K
J Thorac Imaging; 2023 May; 38(3):W33-W42. PubMed ID: 36917505
[TBL] [Abstract][Full Text] [Related]
5. Predictive values of dyslipidemia and B-type natriuretic peptide levels in juvenile systemic lupus erythematosus: A two center-experience.
El-Gamasy MA; Abd Elsalam MM; Abd-El Latif AM; Elsaid HH
Saudi J Kidney Dis Transpl; 2019; 30(4):863-872. PubMed ID: 31464243
[TBL] [Abstract][Full Text] [Related]
6. Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease.
Bañón R; Hernández-Romero D; Navarro E; Pérez-Cárceles MD; Noguera-Velasco JA; Osuna E
Forensic Sci Med Pathol; 2019 Dec; 15(4):528-535. PubMed ID: 31471870
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.
Soker M; Kervancioglu M
Saudi Med J; 2005 Aug; 26(8):1197-202. PubMed ID: 16127512
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
Karadag O; Calguneri M; Yavuz B; Atalar E; Akdogan A; Kalyoncu U; Kiraz S; Aksoyek S; Ozmen F; Ertenli AI
Clin Rheumatol; 2007 Oct; 26(10):1701-4. PubMed ID: 17318274
[TBL] [Abstract][Full Text] [Related]
9. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
10. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
11. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C
Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte injury induced by hemodynamic cardiac stress: Differential release of cardiac biomarkers.
Irfan A; Reichlin T; Twerenbold R; Fischer C; Ballarino P; Nelles B; Wildi K; Zellweger C; Rubini Gimenez M; Mueller M; Haaf P; Fischer A; Freidank H; Osswald S; Mueller C
Clin Biochem; 2015 Dec; 48(18):1225-9. PubMed ID: 26129882
[TBL] [Abstract][Full Text] [Related]
13. Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Baba Y; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
Circ J; 2011; 75(4):919-26. PubMed ID: 21304210
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum cardiac specific biomarker release after non-cardiac thoracic surgery.
Muley T; Kurz M; Männle C; Alekozai A; Winteroll S; Dienemann H; Schmidt W; Pfannschmidt J
Clin Lab; 2011; 57(11-12):925-32. PubMed ID: 22239023
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ulinastatin on myocardial injury in patients with acute severe carbon monoxide poisoning].
Wang P; Li W; Yang JL; Wang Y; Liu Q; Wang WZ; Qi HN; Li J
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Feb; 36(2):154-156. PubMed ID: 29699021
[No Abstract] [Full Text] [Related]
16. Correlations of Changes in Brain Natriuretic Peptide (BNP) and Cardiac Troponin I (cTnI) with Levels of C-Reactive Protein (CRP) and TNF-α in Pediatric Patients with Sepsis.
Zhang Y; Luo Y; Nijiatijiang G; Balati K; Tuerdi Y; Liu L
Med Sci Monit; 2019 Apr; 25():2561-2566. PubMed ID: 30956276
[TBL] [Abstract][Full Text] [Related]
17. Altered Arterial Stiffness, Ventricular-Arterial Coupling and Troponin Levels in Patients with Systemic Lupus Erythematosus.
Kadoglou NPE; Dimopoulou A; Gkougkoudi E; Parperis K
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793004
[No Abstract] [Full Text] [Related]
18. Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer.
Goel S; Simes RJ; Beith JM
Asia Pac J Clin Oncol; 2011 Sep; 7(3):276-80. PubMed ID: 21884439
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of brachial and central blood pressures on circulating levels of high-sensitivity cardiac troponin I in the general population.
Sugiura T; Dohi Y; Takase H; Ito A; Fujii S; Ohte N
Atherosclerosis; 2018 Feb; 269():185-191. PubMed ID: 29366992
[TBL] [Abstract][Full Text] [Related]
20. Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide.
Valaperta R; De Siena C; Cardani R; Lombardia F; Cenko E; Rampoldi B; Fossati B; Brigonzi E; Rigolini R; Gaia P; Meola G; Costa E; Bugiardini R
Atherosclerosis; 2017 Dec; 267():110-115. PubMed ID: 29121498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
